General Information of the Compound
| Compound ID |
CP0542740
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[(3S,8R,9S,10R,13S,14S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl]pyridine-4-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C32H36N4O
|
||||||||||||||||||
| Molecular Weight |
492.667
|
||||||||||||||||||
| Canonical SMILES |
C[C@]12CC[C@H]3[C@@H](CC=C4C[C@H](CC[C@]34C)NC(=O)c3ccncc3)[C@@H]1CC=C2n1cnc2ccccc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C32H36N4O/c1-31-15-11-23(35-30(37)21-13-17-33-18-14-21)19-22(31)7-8-24-25-9-10-29(32(25,2)16-12-26(24)31)36-20-34-27-5-3-4-6-28(27)36/h3-7,10,13-14,17-18,20,23-26H,8-9,11-12,15-16,19H2,1-2H3,(H,35,37)/t23-,24-,25-,26-,31-,32-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
JQTBLQBOBNNBKG-PQFRROSMSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound